StockData
Context Therapeutics Inc. logo

Context Therapeutics Inc. (CNTX) stock

CNTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$0.17−0.01 (-8.24%)

Close on Nov 16, 2026Market cap $15.24MP/E –Yield –

Context Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Context Therapeutics

Context Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Context Therapeutics figures

See a number that looks wrong?